Connect
MJA
MJA

Pharmaceutical preparations

Viewpoint

Low drug doses may improve outcomes in chronic disease

Simon B Dimmitt and Hans G Stampfer

Med J Aust 2009; 191 (9): 511-513 Free

Letters

Naloxone for administration by peers in cases of heroin overdose

Simon R Lenton, Paul M Dietze, Louisa Degenhardt, Shane Darke and Tony G Butler

Med J Aust 2009; 191 (8): 469

Letters

Sociodemographic correlates of antidepressant utilisation in Australia

Magenta B Simmons, Michaela R Willet and Sarah E Hetrick

Med J Aust 2009; 191 (8): 471

Diagnostic dilemmas

An unusual case of recurrent fever, jaundice and right upper quadrant pain

Piers A Blombery, Prudence A Russell and John R Daffy

Med J Aust 2009; 191 (7): 396-397

Letters

Chromobacterium violaceum endocarditis and hepatic abscesses treated successfully with meropenem and ciprofloxacin

Richard N Pearson

Med J Aust 2009; 191 (7): 416

Letters

Inappropriate prescribing for osteoporosis

Ego Seeman, Mark A Kotowicz, Peter T Nash and Philip N Sambrook

Med J Aust 2009; 191 (6): 355-356

Letters

Inappropriate prescribing for osteoporosis

B E Christopher Nordin and Michael Horowitz

Med J Aust 2009; 191 (6): 355-356

Letters

Quality of drug interaction alerts in prescribing and dispensing software

Ian R Cheong

Med J Aust 2009; 191 (6): 358-359

Editorials

Improving the management of chronic non-malignant pain and reducing problems associated with prescription opioids

Alex D Wodak, Milton L Cohen, Malcolm D H Dobbin, Richard A Hallinan and Mary Osborn

Med J Aust 2009; 191 (6): 302-303

Letters

Quality of drug interaction alerts in prescribing and dispensing software

Bryan W Tan

Med J Aust 2009; 191 (6): 358-359

Research

Cost is a major barrier to the use of inhaled corticosteroids for obstructive lung disease

Rosario D Ampon, Helen K Reddel, Patricia K Correll, Leanne M Poulos and Guy B Marks

Med J Aust 2009; 191 (6): 319-323 Free

Letters

Quality of drug interaction alerts in prescribing and dispensing software

Michelle Sweidan, James F Reeve, Jo-anne E Brien, Pradeep Jayasuriya, Jennifer H Martin and Graeme M Vernon

Med J Aust 2009; 191 (6): 358-359

Notable cases

Early use of high-dose insulin euglycaemic therapy for verapamil toxicity

Christopher P Nickson and Mark Little

Med J Aust 2009; 191 (6): 350-352 Free

Letters

Doctors and the pharmaceutical industry: time for a national policy?

Jennifer H Martin, Christopher Beer, Raymond G Morris and Matthew P Doogue

Med J Aust 2009; 191 (3): 189-190

Letters

What changes are needed to the current direction and interpretation of clinical cancer research to meet the needs of the 21st century?

Matthew P Doogue and Kathleen M Knights

Med J Aust 2009; 191 (3): 190

Editorials

The new age of pharmacovigilance

Kathlyn J Ronaldson

Med J Aust 2009; 191 (3): 132-134

Pandemic (H1N1) 2009

Understanding Australia’s influenza pandemic policy on the strategic use of the antiviral drug stockpile

James M McCaw, James G Wood, Emma S McBryde, Terry M Nolan, Joseph T Wu, Marc Lipsitch and Jodie McVernon

Med J Aust 2009; 191 (3): 136-137

Pandemic (H1N1) 2009

Summary of the Australasian Society for Infectious Diseases and the Thoracic Society of Australia and New Zealand guidelines: treatment and prevention of H1N1 influenza 09  (human swine influenza) with antiviral agents

Allen C Cheng, Dominic E Dwyer, A Thomas C Kotsimbos, Mike Starr, Tony M Korman, Jim P Buttery, Christine R Jenkins, Vicki L Krause and Paul D R Johnson

Med J Aust 2009; 191 (3): 142-145

Letters

The quality of medication information in Australia: the need for more clinical expertise and accountability

Caroline E Bulsara and Anne McKenzie

Med J Aust 2009; 191 (3): 189

In Clinical Practice

Medicines for breastfeeding women: a postal survey of general practitioners in Victoria

Lisa H Amir and Marie V Pirotta

Med J Aust 2009; 191 (2): 126

Snapshot

Hand–foot syndrome after treatment with docetaxel

Chitra Sivaramamoorthy, Eddy S Thientosapol and Martin H Tattersall

Med J Aust 2009; 191 (1): 40 Free

Letters

Risks of proton-pump inhibitors: what every doctor should know

Francisco J Fernández-Fernández, Gonzalo Pía and Pascual Sesma

Med J Aust 2009; 190 (11): 652-653

Letters

Risks of proton-pump inhibitors: what every doctor should know

Adam P Morton

Med J Aust 2009; 190 (11): 652-653

Letters

Risks of proton-pump inhibitors: what every doctor should know

Nicholas J Talley, Aneta Dimoska and Kevin Gan

Med J Aust 2009; 190 (11): 652-653

Letters

Varenicline and proximal myopathy

Shelley E Wood and P Gerry Fegan

Med J Aust 2009; 190 (11): 655